Fumiko Oda

530 total citations
24 papers, 293 citations indexed

About

Fumiko Oda is a scholar working on Neurology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Fumiko Oda has authored 24 papers receiving a total of 293 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Neurology, 10 papers in Infectious Diseases and 4 papers in Epidemiology. Recurrent topics in Fumiko Oda's work include Myasthenia Gravis and Thymoma (16 papers), Antifungal resistance and susceptibility (10 papers) and Peripheral Neuropathies and Disorders (9 papers). Fumiko Oda is often cited by papers focused on Myasthenia Gravis and Thymoma (16 papers), Antifungal resistance and susceptibility (10 papers) and Peripheral Neuropathies and Disorders (9 papers). Fumiko Oda collaborates with scholars based in Japan. Fumiko Oda's co-authors include Satoshi Kuwabara, Akiyuki Uzawa, Keiichi Himuro, Naoki Kawaguchi, Tetsuya Kanai, Yukiko Ozawa, Koji Sayama, Mikiko Tohyama, Manato Yasuda and Tamotsu Kanai and has published in prestigious journals such as Scientific Reports, Antioxidants and Redox Signaling and Journal of the Neurological Sciences.

In The Last Decade

Fumiko Oda

20 papers receiving 288 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fumiko Oda Japan 11 204 70 37 31 28 24 293
Inês Chora Portugal 6 46 0.2× 93 1.3× 28 0.8× 61 2.0× 15 0.5× 14 287
Chiara Di Schino Italy 7 348 1.7× 70 1.0× 47 1.3× 25 0.8× 63 2.3× 10 384
Zhiwen Lu China 10 78 0.4× 12 0.2× 53 1.4× 13 0.4× 49 1.8× 29 245
Chenli Chang China 11 40 0.2× 69 1.0× 14 0.4× 58 1.9× 31 1.1× 16 252
Alexander F. Lipka Netherlands 12 292 1.4× 49 0.7× 11 0.3× 23 0.7× 27 1.0× 21 366
Ángela Quintana Spain 6 73 0.4× 129 1.8× 13 0.4× 52 1.7× 16 0.6× 9 258
Tetsuya Kanai Japan 10 222 1.1× 85 1.2× 12 0.3× 16 0.5× 21 0.8× 15 247
Natalie Vaninov United States 5 87 0.4× 149 2.1× 25 0.7× 50 1.6× 35 1.3× 5 297
Liping Xie China 5 46 0.2× 124 1.8× 10 0.3× 15 0.5× 68 2.4× 9 242

Countries citing papers authored by Fumiko Oda

Since Specialization
Citations

This map shows the geographic impact of Fumiko Oda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fumiko Oda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fumiko Oda more than expected).

Fields of papers citing papers by Fumiko Oda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fumiko Oda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fumiko Oda. The network helps show where Fumiko Oda may publish in the future.

Co-authorship network of co-authors of Fumiko Oda

This figure shows the co-authorship network connecting the top 25 collaborators of Fumiko Oda. A scholar is included among the top collaborators of Fumiko Oda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fumiko Oda. Fumiko Oda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oda, Fumiko, Akiyuki Uzawa, Yukiko Ozawa, Manato Yasuda, & Satoshi Kuwabara. (2022). Serum cytokine and chemokine profiles in patients with immune-mediated necrotizing myopathy. Journal of Neuroimmunology. 365. 577833–577833. 9 indexed citations
2.
Ozawa, Yukiko, Akiyuki Uzawa, Manato Yasuda, et al.. (2021). Long-term outcomes and prognostic factors in generalized myasthenia gravis. Journal of Neurology. 268(10). 3781–3788. 9 indexed citations
3.
Sugiyama, Atsuhiko, Yosuke Onishi, Kimiko Ito, et al.. (2021). Marked Respiratory Failure in an Ambulant Patient with Immune-mediated Necrotizing Myopathy and Anti-Kv1.4 and Anti-titin Antibodies. Internal Medicine. 60(16). 2671–2675. 2 indexed citations
4.
Yamamoto, Yohei, Naoko Matsui, Akiyuki Uzawa, et al.. (2021). Intrathymic Plasmablasts Are Affected in Patients With Myasthenia Gravis With Active Disease. Neurology Neuroimmunology & Neuroinflammation. 8(6). 9 indexed citations
5.
6.
Uzawa, Akiyuki, Yukiko Ozawa, Manato Yasuda, et al.. (2019). Increased serum acetylcholine receptor α1 subunit protein in anti-acetylcholine receptor antibody-positive myasthenia gravis. Journal of Neuroimmunology. 339. 577125–577125. 3 indexed citations
7.
Ozawa, Yukiko, Akiyuki Uzawa, Tetsuya Kanai, et al.. (2019). Efficacy of high-dose intravenous methylprednisolone therapy for ocular myasthenia gravis. Journal of the Neurological Sciences. 402. 12–15. 21 indexed citations
8.
Kanai, Tetsuya, Akiyuki Uzawa, Naoki Kawaguchi, et al.. (2018). Predictive score for oral corticosteroid-induced initial worsening of seropositive generalized myasthenia gravis. Journal of the Neurological Sciences. 396. 8–11. 19 indexed citations
9.
10.
Tohyama, Mikiko, et al.. (2017). Case of thymoma‐associated cutaneous graft‐versus‐host disease‐like disease successfully improved by narrowband ultraviolet B phototherapy. The Journal of Dermatology. 45(4). 479–482. 5 indexed citations
11.
Kanai, Tetsuya, Akiyuki Uzawa, Naoki Kawaguchi, et al.. (2016). HLA-DRB1*14 and DQB1*05 are associated with Japanese anti-MuSK antibody-positive myasthenia gravis patients. Journal of the Neurological Sciences. 363. 116–118. 21 indexed citations
12.
Uzawa, Akiyuki, Tetsuya Kanai, Naoki Kawaguchi, et al.. (2016). Relationship between damage‐associated molecular patterns and cytokines in myasthenia gravis. Clinical and Experimental Neuroimmunology. 7(4). 357–360. 1 indexed citations
13.
Uzawa, Akiyuki, Tetsuya Kanai, Naoki Kawaguchi, et al.. (2016). Changes in inflammatory cytokine networks in myasthenia gravis. Scientific Reports. 6(1). 46 indexed citations
14.
Kanai, Tamotsu, Akiyuki Uzawa, Naoki Kawaguchi, et al.. (2016). Adequate tacrolimus concentration for myasthenia gravis treatment. European Journal of Neurology. 24(2). 270–275. 29 indexed citations
15.
Uzawa, Akiyuki, Naoki Kawaguchi, Tetsuya Kanai, et al.. (2015). Increased serum peroxiredoxin 5 levels in myasthenia gravis. Journal of Neuroimmunology. 287. 16–18. 14 indexed citations
16.
Murakami, Masamoto, et al.. (2015). Cefcapene Pivoxil Hydrochloride Is a Potentially New Treatment for Palmoplantar Pustulosis with Pustulotic Arthro-Osteitis. Dermatology. 231(4). 304–311. 12 indexed citations
17.
Uzawa, Akiyuki, Naoki Kawaguchi, Tetsuya Kanai, et al.. (2015). Two-year outcome of thymectomy in non-thymomatous late-onset myasthenia gravis. Journal of Neurology. 262(4). 1019–1023. 22 indexed citations
18.
Oda, Fumiko, et al.. (2015). Bromoderma mimicking pyoderma gangrenosum caused by commercial sedatives. The Journal of Dermatology. 43(5). 564–566. 12 indexed citations
19.
20.
Mori, Takeshi, Fumiko Oda, Daisuke Umeno, Masaru Murata, & Maki Maeda. (1999). Affinity separation of messenger RNA by thermo-responsive polymer carrying oligo(dT). Nucleic Acids Symposium Series. 42(1). 55–56. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Inês Chora Breakdown of academic impact, for papers by Chiara Di Schino Breakdown of academic impact, for papers by Zhiwen Lu Breakdown of academic impact, for papers by Chenli Chang Breakdown of academic impact, for papers by Alexander F. Lipka Breakdown of academic impact, for papers by Ángela Quintana Breakdown of academic impact, for papers by Tetsuya Kanai Breakdown of academic impact, for papers by Natalie Vaninov Breakdown of academic impact, for papers by Liping Xie
Rankless by CCL
2026